Think again, at least if it involves some miniscule pharmaceutical company no one’s ever heard of on the brink of a major breakthrough vis-à-vis Ebola.

“News coverage of Ebola and Middle East Respiratory Syndrome (MERS) is likely to catch the interest of ‘pump and dump’ scammers looking to capitalize on fears of a potential pandemic,” said Gerri Walsh, Finra’s senior vice president for investor education, in a statement.

Finra Warns of Ebola Stock Scams [WSJ MoneyBeat blog]
Investment scammers busy pumping Ebola stocks amid panic [N.Y. Post]

1 comment (hidden to protect delicate sensibilities)
Show all comments ↓

Comments (1)

  1. Posted by LongIslandWolf | August 15, 2014 at 1:12 PM

    Penny stocks ho!